Nasus Pharma Ratios (2024-2025) | NSRX

Ratios Dec2024 Jun2025 Dec2025
Efficiency
Assets Average (Quarter) 0.68M2.82M
Invested Capital (Quarter) -1.41M2.77M
Leverage & Solvency
Debt to Equity (Quarter) -0.56
Debt Ratio (Quarter) 2.51
Equity Ratio (Quarter) -4.480.55
Valuation
Enterprise Value (Quarter) -0.28M-0.23M-4.29M